Premier Alternatives

Synchron

New York, NY · Founded 2016 · Privately Held (backing)

Developer of an implantable stent-rode designed to create a brain-computer interface. Synchron is based in New York, NY and was founded in 2016. It was valued at $385 million at its later-stage round in Dec 2022, the last priced event on record. It has raised $340 million across 1 recorded round; the latest was a $49.9 million early-stage round in Nov 2022.

PMV mark · valuation
$385.0M
Oct 2026
Priced at
its later-stage round
Dec 2022
Total raised
$339.9M
Last round
Early Stage VC
Nov 2022
Prints on record
11
Price range
▮
Latest print
Jun 2026
First print
Oct 2025
Pro
The prices on Synchron
  • ·Every dated print: 11 trades with prices and structures
  • ·4 investment vehicles formed around Synchron: sponsors, sizes, dates
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Synchron market activity

prints per month, every source

11 trades between Oct 2025 and Jun 2026. Exact dates, prices and structures are available to Pro members.

Oct 2025peak 4 prints / monthJun 2026
Individual prints are Pro.Unlock 11 trade prints

Membership and data by Private Market View

Where Synchron prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Synchron stock.